Literature DB >> 17596715

Caenorhabditis elegans as a model system for Parkinson's disease.

Enrico Schmidt1, Mark Seifert, Ralf Baumeister.   

Abstract

Parkinson's disease (PD) is one of the most common age-related neurodegenerative diseases that is characterized by selective loss of dopaminergic neurons. Despite recent findings from mammalian model systems, molecular mechanisms of the pathophysiology are poorly understood. Given the high conservation of molecular pathways from invertebrates to mammalians, combined with technical advantages, such as high-throughput approaches, Caenorhabditis elegans represents a powerful system for the identification of factors involved in neurodegeneration. In this review we describe that C. elegans can be used to advance our understanding of the genetic mechanisms implicated in these disorders. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2007        PMID: 17596715     DOI: 10.1159/000101845

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  13 in total

Review 1.  Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Authors:  Fernando Calahorro; Manuel Ruiz-Rubio
Journal:  Invert Neurosci       Date:  2011-11-08

2.  Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development.

Authors:  Jolene Zheng; Joseph R Vasselli; Jason F King; Michael L King; Wenqian We; Zachary Fitzpatrick; William D Johnson; John W Finley; Roy J Martin; Michael J Keenan; Frederic M Enright; Frank L Greenway
Journal:  Am J Ther       Date:  2016 Nov/Dec       Impact factor: 2.688

Review 3.  Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases.

Authors:  Ebany J Martinez-Finley; Daiana Silva Avila; Sudipta Chakraborty; Michael Aschner
Journal:  Metallomics       Date:  2011-01-06       Impact factor: 4.526

Review 4.  Caenorhabditis elegans as a model system to study intercompartmental proteostasis: Interrelation of mitochondrial function, longevity, and neurodegenerative diseases.

Authors:  Janine Kirstein-Miles; Richard I Morimoto
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

Review 5.  Drug discovery from natural products - Old problems and novel solutions for the treatment of neurodegenerative diseases.

Authors:  Urmila Maitra; Cayman Stephen; Lukasz M Ciesla
Journal:  J Pharm Biomed Anal       Date:  2021-12-24       Impact factor: 3.935

6.  ATP depletion is the major cause of MPP+ induced dopamine neuronal death and worm lethality in alpha-synuclein transgenic C. elegans.

Authors:  Yi-Min Wang; Pu Pu; Wei-Dong Le
Journal:  Neurosci Bull       Date:  2007-11       Impact factor: 5.203

7.  A Systematic RNAi Screen of Neuroprotective Genes Identifies Novel Modulators of Alpha-Synuclein-Associated Effects in Transgenic Caenorhabditis elegans.

Authors:  Pooja Jadiya; Soobiya Fatima; Tanvi Baghel; Snober S Mir; Aamir Nazir
Journal:  Mol Neurobiol       Date:  2015-11-14       Impact factor: 5.590

8.  Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans.

Authors:  Se-Myeong Cheon; Insoo Jang; Myon-Hee Lee; Dae Keun Kim; Hoon Jeon; Dong Seok Cha
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 9.  Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology.

Authors:  Maxwell C K Leung; Phillip L Williams; Alexandre Benedetto; Catherine Au; Kirsten J Helmcke; Michael Aschner; Joel N Meyer
Journal:  Toxicol Sci       Date:  2008-06-19       Impact factor: 4.849

10.  Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model.

Authors:  Ghulam Jeelani Pir; Bikash Choudhary; Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  Mol Neurodegener       Date:  2016-04-27       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.